---
title: "阿斯利康：在 BAXHTN III 期试验中巴昔多司他（baxdrostat）使患者的收缩压出现了具有临床意义的降低。 阿斯利康将于年底前为该药申请批准。"
description: "阿斯利康：在 BAXHTN III 期试验中巴昔多司他（baxdrostat）使患者的收缩压出现了具有临床意义的降低。 阿斯利康将于年底前为该药申请批准。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/255314923.md"
published_at: "2025-08-30T14:16:00.000Z"
---

# 阿斯利康：在 BAXHTN III 期试验中巴昔多司他（baxdrostat）使患者的收缩压出现了具有临床意义的降低。 阿斯利康将于年底前为该药申请批准。

阿斯利康：在 BAXHTN III 期试验中巴昔多司他（baxdrostat）使患者的收缩压出现了具有临床意义的降低。 阿斯利康将于年底前为该药申请批准。

### Related Stocks

- [AZN.US - 阿斯利康](https://longbridge.com/zh-CN/quote/AZN.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Trump Strikes Again: AstraZeneca's Surprise Drug Deal Could Shake Big Pharma's Global Pricing Power | AstraZeneca has reached a drug-pricing deal with President Trump to reduce Medicaid drug prices, potentially reshaping B | [Link](https://longbridge.com/zh-CN/news/260941568.md) |
| ANALYSIS-AstraZeneca's US listing may pull other firms from London in its wake | AstraZeneca's decision to upgrade its U.S. listing while retaining its London presence may influence other UK firms to c | [Link](https://longbridge.com/zh-CN/news/259563996.md) |
| Tempus AI EVP Erik Phelps Sells Shares | Erik Phelps, EVP and Chief Admin. Officer of Tempus AI, sold 9,464 shares of Class A Common Stock on February 19, 2026,  | [Link](https://longbridge.com/zh-CN/news/276495655.md) |
| Annette Franqui Purchases 1,540 Shares of OFG Bancorp (NYSE:OFG) Stock | OFG Bancorp Director Annette Franqui purchased 1,540 shares of the company's stock at $42.06 per share, totaling $64,772 | [Link](https://longbridge.com/zh-CN/news/276494822.md) |
| ConocoPhillips considers selling Permian assets worth $2 billion, Bloomberg News reports | Feb 20 (Reuters) - ConocoPhillipsis exploring a sale of some of its Permian Basin assets as part of a broader streamlini | [Link](https://longbridge.com/zh-CN/news/276478732.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。
